Croatia Pharmaceuticals & Healthcare Report Q2 2018
The outlook for medicine sales growth in Croatia over the coming years will appear favourable relative to the majority ofits EEA member peers. The market continues to develop, exemplified by the rising demand for high-value cancer medicines. Thatsaid, innovative drugmakers will face a multitude of risks stemming from healthcare funding issues. Moreover, market growth willremain subdued compared with its emerging European neighbours.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook